Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-20-031021

President and CEO sold 13,514 shares at an average $30.83 ($416,686)

  • President and CEO acquired 13,514 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · President and CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-07 Exercise or conversion : show line 1 in the form +4,666 $0.61 $2,846 328,466 D
2020-12-07 Sale : show line 2 in the form −4,666 $30.02 $140,065 323,800 D
2020-12-08 Exercise or conversion : show line 3 in the form +8,848 $0.61 $5,397 332,648 D
2020-12-08 Sale : show line 4 in the form −4,050 $30.96 $125,388 328,598 D
2020-12-08 Sale : show line 5 in the form −4,798 $31.52 $151,233 323,800 D
Open-market sales · 13,514 sh · avg $30.83 · $416,686

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-12-07 Exercise or conversion : show line 6 in the form Stock Option −4,666 $0.61 2027-06-28 4,666 46,200 D
2020-12-08 Exercise or conversion : show line 7 in the form Stock Option −8,848 $0.61 2027-06-28 8,848 37,352 D
Loading xslF345X03/form4.xml…